Industries > Pharma > Global Rheumatoid Arthritis Drugs Market Forecast 2020-2030

Global Rheumatoid Arthritis Drugs Market Forecast 2020-2030

Biologics, Non-Biologics, NSAIDs, sDMARDs and Others

PUBLISHED: 17 February 2020
PAGES: 236
PRODUCT CODE: PHA0671
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
SKU: PHA0671 Categories: , Tags: , , ,

The global Rheumatoid Arthritis market is estimated to have reached $58bn in 2018 and is expected to grow at a CAGR of 0.6% in the second half of the forecast period. In 2018, the biologics submarket held 85% of the global Rheumatoid Arthritis market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 236-page report you will receive 180 tables and 121 figures– all unavailable elsewhere.

The 236-page report provides clear detailed insight into the rheumatoid arthritis market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Rheumatoid Arthritis Market forecast from 2020-2030

• Revenue forecasts for the Rheumatoid Arthritis Market by Drug Class from 2020-2030:
• Biologics
• Non-Biologics: NSAIDs, sDMARDs, Others

• Revenue forecasts for the Rheumatoid Arthritis Market by Drugs from 2020-2030:
• Humira
• Enbrel
• Remicade
• Rituxan/MabThera
• Simponi/Simponi Aria
• Orencia
• Actemra/Roactemra
• Cimzia
• Celebrex
• Xeljanz
• Arcoxia
• Others

• Revenue forecasts for the Rheumatoid Arthritis Market by Region from 2020-2029:
• North America: U.S., Canada
• Europe: Germany, UK, France, Italy, Spain, Russia, Rest of Europe
• Asia-Pacific: Japan, China, India, Rest of Asia-Pacific
• Latin America: Brazil, Mexico, Rest of Latin America
• Middle East & Africa: Saudi Arabia, South Africa, Rest of MEA

Global Rheumatoid Arthritis Drugs Market Forecast 2020-2030

• Profiles of these selected leading companies:
• AbbVie
• Amgen, Inc.
• Bristol-Myers Squibb
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• Johnson & Johnson
• Merck & Co.
• Novartis AG
• Pfizer
• Sanofi S.A.
• UCB

• Analysis of the Drivers, Restraints, Opportunities and Threats of the global rheumatoid arthritis drugs market

• The report also includes SWOT Analysis of the Global rheumatoid arthritis drugs market

• Key questions answered by this report:
• How is the Rheumatoid Arthritis drugs market evolving?
• What is driving and restraining the Rheumatoid Arthritis drugs market?
• What are the market shares of each segment of the overall Rheumatoid Arthritis drugs market in 2018?
• How will each Rheumatoid Arthritis drugs submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2030?
• How will the market shares for each Rheumatoid Arthritis drugs submarket develop from 2020 to 2030?
• Which individual therapies will prevail and how will these shifts be responded to?
• What will be the main driver for the overall market from 2020 to 2030?
• How will the market shares of the national markets change by 2030 and which geographical region will lead the market in 2030?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve during the period between 2020 and 2030?

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Rheumatoid Arthritis Drugs Market. You find data, trends and predictions.

Buy our report today Global Rheumatoid Arthritis Drugs Market Forecast 2020-2030: Prospects for Biologics, Non-Biologics (NSAIDs, sDMARDs and Others).

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Global Rheumatoid Arthritis Drugs Market Forecast 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Global Rheumatoid Arthritis Drugs Market Forecast 2020-2030


Latest Pharma news

Visiongain Publishes Generic Drugs Market Report 2020-2030

The 431-page report provides clear detailed insight into the generic drugs market. Discover the key drivers and challenges affecting the market.

03 July 2020

READ

Visiongain publishes Clinical Workflow Solutions Market Report 2020-2030

Where is the Clinical Workflow Solutions market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.

03 July 2020

READ

Visiongain Publishes Clinical Trials Market Report 2020-2030

With the growing burden of rare diseases around the world, there has been a rise and advancement in the therapy development of these types of diseases. While the fact remains that over 90% of these diseases lack approval for treatment and the total number of terminal rare diseases to receive the first treatment every year remains low.

01 July 2020

READ

Visiongain Publishes Clinical Risk Grouping Solutions Market Report 2020-2030

The market growth is attributed to the growing adoption of big data and AI in data management and monitoring of clinical information in health care.

01 July 2020

READ

Categories

Category